Medical network - on March 22, medical apparatus and instruments industry reshuffle or will speed up. Beijing commercial daily reporter rough statistics, as of now, 43 medical equipment company, has 28 disclose earnings forecast in 2016. Among them, 18 net profit increase, decline in six, four uncertainty. The whole plate performance growth slowed significantly. Under the background of regulation increasingly strict, industry reshuffle will speed up.
The 28 companies operating income in 2016 year-on-year growth of about 3% on average, net profit growth of about 5% on average. Net profit increase of 18 companies, more than 30% year-on-year growth of treasure Wright, shares thereof, nine medical companies such as Ann.
Net profit fell by more than 20% of the company include YangPu medical, sanxin three companies such as biology, medical treatment, for the cause of the decline in performance, the reason of these companies are basically the same, affected by the overall economic environment downward and industry policy, the pharmaceutical industry growth is slowing, pharmaceutical equipment demand, market competition is intense.
Equipment manufacturing industry is an important link of pharmaceutical production. To the boom of industry downturn, Chinese medicine enterprise management association ming-de yu has said that the domestic equipment manufacturing level is low, only satisfy certain link, in many cases difficult to provide the whole production line production of form a complete set, high profit part is often overseas enterprises. In addition, the domestic pharmaceutical enterprise production management backwardness, take the initiative to improve production line product quality production efficiency awareness. Data shows, at present nearly 1.6 Chinese medical equipment manufacturing enterprises, production enterprises tend to as many as dozens of similar product, and even hundreds of, have different production standards between enterprises, the overall level is uneven. Since 2016, the camp is implemented by the state in the pharmaceutical industry to increase, two votes, such as policy, these factors will hasten industry reshuffle. |
